Lukas Scheibler

Title: Innovations of Lukas Scheibler

Introduction

Lukas Scheibler is a prominent inventor based in Telluride, Colorado, known for his significant contributions to the field of ophthalmic technology. With a total of 17 patents to his name, he has developed groundbreaking solutions that enhance vision care and improve patient outcomes.

Latest Patents

One of his latest innovations is the heat tunable intraocular lens. This invention features a lens body with a chamber and a reservoir module that is coupled with the lens body. The lens includes an optical fluid, and at least part of the lens body is flexible. The reservoir module contains a reservoir and a heat-sensitive portion that changes shape in response to temperature, allowing for adjustments in the reservoir volume. This mechanism enables the optical fluid to flow between the reservoir and the chamber, resulting in a shape change of the lens body that corresponds to a base power change.

Another notable patent is the miniaturized mobile, low-cost optical coherence tomography system designed for home-based ophthalmic applications. This system allows for improved measurement of retinal thickness and is compact and handheld, enabling patients to monitor their own eye health from home. The system is robust enough to withstand drops while still providing reliable measurements.

Career Highlights

Lukas has worked with several notable companies in the ophthalmic field, including Acucela Inc. and Novartis AG. His experience in these organizations has contributed to his expertise and innovative approach to developing new technologies.

Collaborations

Throughout his career, Lukas has collaborated with talented individuals such as Stefan Troller and Matthias Pfister. These partnerships have fostered a creative environment that has led to the development of his innovative patents.

Conclusion

Lukas Scheibler's contributions to ophthalmic technology through his patents demonstrate his commitment to improving vision care. His innovative solutions have the potential to transform the way patients monitor and manage their eye health.